Association of the aldosterone synthase gene C-344T polymorphism with risk factors and survival in a post-myocardial infarction cohort

Journal of Human Hypertension

Volumn 21, Issue 3, 2007, Pages 256-258

  Baird, T E ^a   Palmer, B R ^a   Frampton, C M ^a   Yandle, T G ^a   Skelton, L ^a   Richards, A M ^a   Cameron, V A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; NATRIURETIC FACTOR; SODIUM;

ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PROMOTER REGION; REGULATOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM LOAD; SURVIVAL; TRANSCRIPTION REGULATION; UNIVARIATE ANALYSIS;

ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; HYPERTENSION; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEW ZEALAND; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL RATE;

EID: 33847035957     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002130     Document Type: Article

References (12)

1. Connell JM, Fraser R, MacKenzie SM, Friel EC, Ingram MC, Holloway CD et al. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 2004; 217: 243-247.
2. Bassett MH, White PC, Rainey WE. The regulation of aldosterone synthase expression. Mol Cell Endocrinol 2004; 217: 67-74.
3. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97: 569-575.
4. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E et al. Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxford) 2004; 61: 174-181.
5. Casiglia. E, Tikhonoff V, Mazza A, Rynkiewicz A, Limon J, Caffi S et al. C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: A population-based study. J Hypertens 2005; 23: 1991-1996.
6. Delles C, Erdmann J, Jacobi J, Hilgers K, Fleck E, Regitz-Zagrosek V et al. Aldosterone synthase (CYP11B2) -344C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am College Cardiol 2001; 37: 878-884.
7. Richards A, Nicholls M, Yandle T, Ikram H, Espiner E, Turner J et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 1999; 81: 114-120.
8. Richards AM, Nicholls MG, Troughton RW, Lainchbury JG, Elliott J, Frampton C et al. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182-1188.
9. Connell JM, Fraser R, MacKenzie S, Davies E. Is altered adrenal steroid biosynthesis a key intermediate pheno-type in hypertension? Hypertension 2003; 41: 993-999.
10. Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation 2006; 113: 977-985.
11. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11: 856-860.
12. McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Taylor AL et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: Results from the A-HeFT Trial. J Am Coll Cardiol 2006; 48: 1277-1282.